Definition:Prescribed capital requirement (PCR)
🛡️ Prescribed capital requirement (PCR) is the minimum amount of regulatory capital that an insurer must hold as determined by its supervisory authority, representing the threshold below which regulatory intervention becomes mandatory. The term is most closely associated with the regulatory frameworks of certain Asia-Pacific jurisdictions — notably Singapore, where the Monetary Authority of Singapore (MAS) uses the PCR as a central pillar of its risk-based capital regime — and with the International Association of Insurance Supervisors ( IAIS) Insurance Capital Standard (ICS), which employs similar terminology. Although the precise label differs across markets — the Solvency II framework uses " Solvency Capital Requirement" while the U.S. system relies on the NAIC's RBC formula — the underlying concept is shared: a risk-sensitive capital floor calibrated to the insurer's specific risk profile.
⚙️ Calculation of the PCR typically involves applying prescribed factors or models to the major risk categories an insurer faces — underwriting risk, credit risk, market risk, operational risk, and concentration risk. In Singapore's framework, insurers compute a total risk requirement across these categories and must maintain eligible capital above the PCR at all times; breaching this threshold triggers a cascade of supervisory actions, from enhanced reporting obligations to restrictions on business activities and dividend distributions. Some jurisdictions permit insurers to use approved internal models rather than the standardized formula, which can produce a PCR that more accurately reflects the insurer's unique risk profile but requires extensive validation and regulatory approval. The IAIS's development of the ICS has sought to harmonize these approaches internationally, establishing a common language for group-level capital requirements applicable to internationally active insurance groups.
📊 The PCR serves as the hard boundary between an insurer operating under normal supervisory oversight and one subject to escalating intervention — making it arguably the single most consequential number on a regulated insurer's balance sheet. Boards and senior management track the ratio of available capital to the PCR (often expressed as a capital adequacy ratio or CAR) as a key indicator of financial health, and rating agencies incorporate these ratios into their assessments. For reinsurers and cedants negotiating security arrangements, the counterparty's standing relative to its PCR is a critical factor in evaluating counterparty risk. As global regulatory convergence accelerates — driven by the IAIS's Common Framework ( ComFrame) and the gradual adoption of the ICS — understanding the PCR and its equivalents across jurisdictions has become essential for any insurer or insurance group operating across borders.
Related concepts: